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Cerebral tuberculosis kills or disables a higher proportion
of sufferers than any other form of tuberculosis, yet little
is known about the pathogenesis. The seminal studies of
Rich and McCordock, performed more than 70 years ago,
demonstrated that the development of tuberculous men-
ingitis requires two steps. First, bacteria travel in the blood
from the lungs to the meninges where they form discrete
foci of infection (Rich foci). Second, foci rupture and
release bacteria into the subarachnoid space so heralding
the onset of meningitis [1]. Our understanding of the
pathogenesis of cerebral tuberculosis has advanced little
since these studies.
The primary focus of tuberculous infection is almost
always the lung, but how bacteria travel from lung to
blood – a critical step in the development of all extra-pul-
monary disease – is unknown. M. tuberculosis primarily
infects pulmonary alveolar macrophages, which may
transport bacteria from the alveolus to the blood. How-
ever, the discovery that M. tuberculosis haematogenous dis-
semination was dependent upon heparin-binding
haemagglutinin adhesin, a bacterial virulence factor that
interacts with epithelial cells, suggests other trafficking
pathways may be important [2]. Animal models of tuber-
culosis have reported bacteria can be found in the blood
soon after pulmonary infection and before the onset of
adaptive immunity. Consequently, it is hypothesized that
the development of disseminated tuberculosis reflects a
failure of the innate immune response to infection.
Human studies have shown an association between the
development of tuberculous meningitis and polymor-
phisms in genes encoding Toll-like receptor-2 and TIRAP
(an adaptor protein that mediates signals from Toll-like
receptors). Recently, we have shown some strains of M.
tuberculosis may be more capable of causing disseminated
disease than others [3] and there is increasing evidence
that different strains elicit different innate immune
responses.
Once M. tuberculosis reaches the brain the nature of the
inflammatory response has long been considered impor-
tant in determining clinical outcome. A rabbit model of
tuberculous meningitis suggested tumour necrosis factor
alpha (TNF-γ) was a critical determinant of disease sever-
ity and progression [4], which led to trials of thalidomide
(a TNF-γ antagonist) in humans [5]. Sadly, thalidomide
did not benefit children with the disease suggesting a
more complex role for TNF-γ in human disease. However,
controlled trials of adjunctive corticosteroids in children
[6] and adults [7] have shown these drugs improve out-
come, although this effect has not been clearly linked to
decreased intra-cerebral inflammation and the determi-
nants of a protective rather than a destructive immune
response remain unclear.
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